References
- Bielsa S, Salud A, Martinez M, et al (2008). Prognostic significance of pleural fluid data in patients with malignant effusion. Eur J Intern Med, 19, 334-9. https://doi.org/10.1016/j.ejim.2007.09.014
- Bollig-Fischer A, Dewey TG, Ethier SP (2011). Oncogene activation induces metabolic transformation resulting in insulin-independence in human breast cancer cells. PLoS One, 6, 17959. https://doi.org/10.1371/journal.pone.0017959
- Ernam D, Atalay F, Hasanoglu HC, Kaplan O (2005). Role of biochemical tests in the diagnosis of exudative pleural effusions. Clin Biochem, 38, 19-23. https://doi.org/10.1016/j.clinbiochem.2004.09.023
- Ghayumi SMA, Aghasadeghi K, Doroudchi M, Ghaderi A (2006). Determination of soluble HER-2/neu (sher-2/neu) in iranian patients with lung cancer. Iran J Immunol, 3, 61-5.
- Harris LN, Liotcheva V, Broadwater G, et al (2001). Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapy. J Clin Oncol, 19, 1698-706. https://doi.org/10.1200/JCO.2001.19.6.1698
- Heffner JE, Klein JS (2008). Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc, 83, 235-50. https://doi.org/10.1016/S0025-6196(11)60848-3
- Hirsch FR, Franklin WA, Bunn PA (2002a). What is the role of HER-2/neu and trastuzumab (Herceptin) in lung cancer? Lung Cancer, 36, 263-4. https://doi.org/10.1016/S0169-5002(02)00011-9
- Hirsch FR, Varella-Garcia M, Franklin WA, et al (2002b). Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas. Br J Cancer, 86, 1449-56. https://doi.org/10.1038/sj.bjc.6600286
- Limthongkul S (1989). The pathogenesis of low pleural fluid glucose in acidotic malignant pleural effusions. J Med Assoc Thai, 72, 492-7.
- Masoompour SM, Yarmohammadi H, Rezaianzadeh A, Lankarani KB (2011). Cancer incidence in southern Iran, 1998-2002: results of population-based cancer registry. Cancer Epidemiol, 35, 42-7. https://doi.org/10.1016/j.canep.2011.05.018
- Mojtahedi Z, Safaei A, Yousefi Z, Ghaderi A (2011). Immunoproteomics of HER2-positive and HER2-negative breast cancer patients with positive lymph nodes. OMICS, 15, 409-18. https://doi.org/10.1089/omi.2010.0131
- Panagiotou I, Georgiannos SN, Tsiambas E, et al (2012). Impact of HER2 and PTEN simultaneous deregulation in non-small cell lung carcinoma: correlation with biological behavior. Asian Pac J Cancer Prev, 13, 6311-8. https://doi.org/10.7314/APJCP.2012.13.12.6311
- Pirker R, Minar W (2010). Chemotherapy of advanced non-small cell lung cancer. Front Radiat Ther Oncol, 42, 157-63.
- Sanchez-Armengol A, Rodriguez-Panadero F (1993). Survival and talc pleurodesis in metastatic pleural carcinoma, revisited. Report of 125 cases. Chest, 104, 1482-5. https://doi.org/10.1378/chest.104.5.1482
- Xia Q, Zhu Z, Wang J, et al (2012). Expression and association of HER2 with prognosis in early-stage (T1-T2N0M0) nonsmall cell lung cancer. Tumour Biol, 33, 1719-25. https://doi.org/10.1007/s13277-012-0429-9
- Zahir ST, Mirtalebi M (2012). Survival of patients with lung cancer, Yazd, Iran. Asian Pac J Cancer Prev, 13, 4387-91. https://doi.org/10.7314/APJCP.2012.13.9.4387
- Zhao YH, Zhou M, Liu H, et al (2009). Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth. Oncogene, 28, 3689-701. https://doi.org/10.1038/onc.2009.229
- Zinner RG, Glisson BS, Fossella FV, et al (2004). Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpressing disease. Lung Cancer, 44, 99-110. https://doi.org/10.1016/j.lungcan.2003.09.026
Cited by
- Glucose May Attenuate Isoflurane-Induced Caspase-3 Activation in H4 Human Neuroglioma Cells vol.119, pp.6, 2014, https://doi.org/10.1213/ANE.0000000000000383
- Prediction of Lung Cancer Based on Serum Biomarkers by Gene Expression Programming Methods vol.15, pp.21, 2014, https://doi.org/10.7314/APJCP.2014.15.21.9367
- Molecular epidemiology of lung cancer in Iran: implications for drug development and cancer prevention vol.63, pp.7, 2018, https://doi.org/10.1038/s10038-018-0450-y